Deerfield Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 50
- Investments
- 294
- Portfolio
- 107
- Exits
- 166
Deerfield Management General Information
Description
Founded in 1994, Deerfield Management is a venture capital firm headquartered in New York, New York. The firm seeks to invest in the healthcare, pharmaceutical, biotechnology, healthcare devices, diagnostic, digital health, supplies, healthcare services, life sciences, and oncology sectors.
Contact Information
Website
www.deerfield.com
Year Founded
1994
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Hedge Fund
Primary Office
- 345 Park Avenue South
- New York, NY 10010
- United States
+1 (212) 000-0000
Deerfield Management Investments (294)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Vibliome Therapeutics | 24-Feb-2022 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 00000 000000000000 |
| 0000000 | 23-Feb-2022 | 00000 00000 | 00000 | Clinics/Outpatient Services | Generating Revenue | 000000 000000 00 |
| 0000 00 0000 00000 | 30-Dec-2021 | 0000000000 | Elder and Disabled Care | Generating Revenue | ||
| 000000000000 | 22-Dec-2021 | 00000 00000 | 00000 | Elder and Disabled Care | Generating Revenue | 000000 0000000 |
| 000000000 (0000000 | 22-Dec-2021 | 0000 | 00000 | Diagnostic Equipment | Generating Revenue | |
| 00000 000000000 | 08-Dec-2021 | 0000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | |
| 0000000 000000 000 | 07-Dec-2021 | 0000000000 | Elder and Disabled Care | Generating Revenue | ||
| 000 00000000 00000 | 15-Nov-2021 | 0000 | 00000 | Hospitals/Inpatient Services | Generating Revenue/Not Profitable | |
| Blade Therapeutics | 08-Nov-2021 | PIPE | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 00000000 |
| Lark (Other Healthcare Services) | 13-Oct-2021 | Later Stage VC | 00000 | Other Healthcare Services | Generating Revenue | 000000 000000 00 |
Deerfield Management Exits (166)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Xilio Therapeutics | 22-Oct-2021 | IPO | 00000 |
| 000000000 | 21-Oct-2021 | 000000000000000000 | 00000 |
| 000000000 (0000000 | 15-Oct-2021 | 000000 00 000000 | |
| 000000000 | 06-Aug-2021 | 000000000000000000 | 00000 |
| 00000000 | 29-Jul-2021 | 000 | 00000 |
| 0000 0000 0000000 | 28-Jul-2021 | 000 | 00000 |
| 00000 | 22-Jul-2021 | 0000000 000000 | 00000 |
| 000000 0000000 | 15-Jul-2021 | 000000 0000000000 | 0000 |
| GH Research | 25-Jun-2021 | IPO | 00000 |
| Graphite Bio | 25-Jun-2021 | IPO | 00000 |
Deerfield Management Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Deerfield Management‘s full profile, request access.
Request a free trialDeerfield Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialDeerfield Management Team (81)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jonathan Isler | Chief Financial Officer & Partner | New York, NY | |||
| Alexis Cazé | Partner & Chief Operating Officer | New York, NY | |||
| Jana Jensen Ph.D | Chief Operating Officer, Deerfield Discovery and Development | 0 | New York, NY | ||
| Angelo Stornello | Chief Technology Officer | New York, NY | |||
| James Flynn | Managing Partner | 00 | 0 | 0 | New York, NY |
Deerfield Management Co-Investors (353)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 15 | 0 | 00 |
|
|
| OrbiMed | 00 | 0 | 00 |
|
|
| Cormorant Asset Management | 00 | 0 | 0 |
|
|
| Logos Capital | 0 | 0 |
|
|
|
| Perceptive Advisors | 0 | 0 | 0 |
|
|